01099.HK
Sinopharm Group Co. Ltd.
HKSE · Healthcare · Medical - Distribution · CN
HKD 15.69
+1.49%Margins
Gross margin
7.3%
EBITDA margin
3.6%
EBIT margin
2.8%
Net margin
1.2%
FCF margin
1.1%
16.3%
Return on equity
3.4%
Return on assets
16.0%
Return on invested capital
2.88x
Asset turnover
HKD 16.5B
Cash from operations
HKD 16
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026